Low dose of emicizumab could be as effective as standard dose against Haemophilia A, according to a study led by the Indian ...

The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...

Novo Nordisk NVO announced new data from the phase III FRONTIER clinical program, comprising five separate studies evaluating ...

In Hooghly district, haemophilia injections have not been available at either Chinsurah Imambara Hospital or Arambagh Medical ...

A cost-effective point-of-care test kit has been developed in India for early diagnosis of haemophilia A and Von Willebrand Disease, offering a more accessible alternative to expensive lab tests. This ...

Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...

Positive phase I/II data presented at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress show ...

The Indian Council of Medical Research's National Institute of Immunohaematology (ICMR's NIIH) has developed a cost-effective ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

The National Institute of Immunohaematology has developed a cost-effective test kit for early diagnosis of hemophilia A and ...

Factor IX, and FEIBA (Anti-Inhibitor Coagulant Complex), which are critical for preventing fatal bleeds in patients with the ...